Inspire Medical Systems (INSP) Q2 FY26 earnings call

Inspire Medical Systems delivered Q2 FY26 results ahead of expectations, driven by disciplined cost management and strong sales execution, despite a 7.6% revenue decrease due to ongoing coding and reimbursement disruption. The company launched "Project Horizon" to optimize operations and free up $30 million for growth initiatives, while increasing its full-year outlook for revenue and adjusted profitability. Management is actively addressing reimbursement clarity and is encouraged by proposed 2027 facility reimbursement increases, though physician fees are expected to decline.